Rights and permissions
About this article
Cite this article
“Significant cost savings” accrued with discontinuation of HAART. Pharmacoecon. Outcomes News 485, 9 (2005). https://doi.org/10.2165/00151234-200504850-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504850-00016